Eventide Asset Management - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 406 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$14,866,784
+5.9%
122,6430.0%0.27%
+12.7%
Q2 2023$14,045,076
-45.6%
122,643
-34.5%
0.24%
-50.0%
Q1 2023$25,811,148
-50.3%
187,268
-73.1%
0.47%
-38.4%
Q1 2021$51,959,000
-67.3%
697,156
-25.2%
0.77%
-68.4%
Q4 2020$158,813,000
+21.4%
931,5120.0%2.44%
-4.9%
Q3 2020$130,812,000
-18.1%
931,512
-6.5%
2.56%
-26.2%
Q2 2020$159,699,000
+63.9%
996,0000.0%3.47%
+10.0%
Q1 2020$97,429,000
-24.2%
996,0000.0%3.16%
-12.9%
Q4 2019$128,524,000
+40.0%
996,000
-18.3%
3.62%
+19.3%
Q3 2019$91,815,000
-46.2%
1,219,000
+8.5%
3.03%
-41.5%
Q2 2019$170,640,000
+69.4%
1,123,000
+32.9%
5.19%
+49.7%
Q1 2019$100,736,000
+9.2%
845,1680.0%3.47%
-15.1%
Q4 2018$92,233,000
-7.9%
845,168
+36.3%
4.08%
+11.0%
Q3 2018$100,136,000
+102.0%
620,000
+65.3%
3.68%
+78.8%
Q2 2018$49,568,000
+196.0%
375,000
+65.9%
2.06%
+162.4%
Q1 2018$16,744,000
+86.9%
226,000
+40.4%
0.78%
+67.9%
Q4 2017$8,958,000
+22.7%
161,0000.0%0.47%
+12.8%
Q3 2017$7,303,000
+12.6%
161,000
-51.5%
0.41%
+14.4%
Q1 2016$6,486,000
-49.4%
332,3000.0%0.36%
-43.5%
Q4 2015$12,820,000
+22.3%
332,300
+1.8%
0.64%
+5.3%
Q3 2015$10,481,000
+32.9%
326,400
+26.0%
0.61%
+42.6%
Q2 2015$7,884,000
+129.1%
259,1000.0%0.43%
+64.9%
Q1 2015$3,441,000
-8.2%
259,1000.0%0.26%
-36.7%
Q4 2014$3,749,000
-31.4%
259,1000.0%0.41%
-46.4%
Q3 2014$5,467,000
-29.2%
259,1000.0%0.76%
-27.3%
Q2 2014$7,719,000
+24.0%
259,1000.0%1.05%
+8.6%
Q1 2014$6,226,000
+115.6%
259,100
+82.7%
0.97%
+8.7%
Q4 2013$2,888,000141,8000.89%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders